Reference of 1317-39-1, In heterogeneous catalysis, catalysts provide a surface to which reactants bind in a process of adsorption. Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction.In an article, once mentioned the application of 1317-39-1, Name is Copper(I) oxide, is a conventional compound.
The present invention relates to compounds of the formula: STR1 and the pharmaceutically acceptable salts thereof, wherein Z can be: STR2 wherein R 3 is alkyl having 1 to 6 carbon atoms and, when n is greater than 1, each R 3 can be the same or different; and n is an integer from 1 to 3;
R 1 and R 2 can each independently be hydrogen, straight or branched chain alkyl, or cycloalkyl having 3 to 8 carbon atoms which can optionally be substituted at one or more positions by alkyl of 1 to 6 carbon atoms; X is oxygen, sulfur, NR 4, wherein R 4 is hydrogen or alkyl having 1 to 4 carbon atoms, C=O, CHOH, or CH 2 ; Y is hydrogen, alkoxy, halogen, alkyl, or hydroxy; and m is an integer from 0 to 3. The compounds are antagonists of platlet-activating factor (PAF).
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Reference of 1317-39-1, you can also check out more blogs aboutReference of 1317-39-1
Reference：
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”